Classification of filtering blebs in trabeculectomy: Biomicroscopy and functionality

Current Opinion in Ophthalmology

Volumn 9, Issue 2, 1998, Pages 2-8

  Picht, Greda ^a   Grehn, Franz ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMICROSCOPY; CONJUNCTIVA; GLAUCOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; TRABECULECTOMY; WOUND HEALING;

EID: 0031801077     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-199804000-00002     Document Type: Review

References (48)

1. Cairns JE: Trabeculectomy. Am J Ophthalmol 1968, 66:673-679.
2. Mills KB: Trabeculectomy: a retrospective long-term follow-up of 444 cases. Br J Ophthalmol 1981, 65:790-795.
3. Five-year follow-up of the fluorouracil filtering surgery study. Am J Ophthalmol 1996, 121:349-366.
4. Chen TC, Wilensky JT, Viana MAG: Long-term follow-up of initially successful trabeculectomy. Ophthalmology 1997, 104:1120-1125.
5. Vesti E: Filtering blebs: follow-up of trabeculectomy. Ophthalmic Surg Lasers 1993, 24:249-255. Retrospective study of the correlation of biomicroscopic appearance to the function of filtering blebs after trabeculectomy.
6. Lederer CM: Combined cataract extraction with intraocular lens implant and mitomycin-augmented trabeculectomy. Ophthalmology 1996, 103:1025-1034.
7. Grehn F, Mauthe S, Pfeiffer N: Limbus-based versus fornix-based conjunctival flap in filtering surgery. Int Ophthalmol 1989, 13:139-143.
8. Shingleton BJ: Management of the failing glaucoma filter. Surg Rev 1996, 27:445-451. Classification of filtering blebs by morphologic criteria to recognize early warning signs of bleb failure.
9. Picht G, Grehn F: Classification of filtering blebs: a correlation to outcome 3 months after trabeculectomy [ARVO abstract]. Invest Ophthalmol Vis Sci 1997, 38:1060.
10. Watson PG, Jakeman C, Ozturk M, Barnett MF, Barnett F, Khaw KT: The complications of trabeculectomy (a 20-year follow-up). Eye 1990, 4:425-438.
11. Liebmann JM, Sokol J, Ritch R: Management of chronic hypotony after glaucoma filtration surgery. Journal of Glaucoma 1996, 5:210-220.
12. Lynch MG, Roesch M, Brown RH: Remodeling filtering blebs with the Neodymium: YAG Laser. Ophthalmology 1996, 103:1700-1705.
13. Asrani SG, Wilensky JT: Management of bleb leak after glaucoma filtering surgery. Ophthalmology 1996, 103:294-298.
14. Smith MF, Doyle W: Use of oversized bandage soft contact lenses in the management of early hypotony following filtration surgery. Ophthalmic Surg Lasers 1996, 27:417-421.
15. Kosmin AS, Wishart PK: A full-thickness scleral graft for the surgical management of a late filtration bleb leak. Ophthalmic Surg Lasers 1997, 28:461-468.
16. Schwartz GF, Robin AL, Wilson RP, Suan EP, Pheasant TR, Prensky JG: Resuturing the scleral flap leads to resolution of hypotony maculopathy. Journal of Glaucoma 1996, 5:246-251.
17. Siegfried CJ, Grewal RK, Karalekas D, Rosenberg LF, Krupin T: Marked intraocular pressure rise complicating intrableb autologous blood injection. Arch Ophthalmol 1996, 114:492-493.
18. Belyea DA, Dan JA, Stamper RL, Lieberman MF, Spencer WH: Late onset of sequential multifocal bleb leaks after glaucoma filtering surgery with 5-fluorouracil and mitomycin C. Am J Ophthalmol 1997, 124:40-45.
19. Greenfield DS, Suner IJ, Miller MP, Kangas TA, Palmberg PF, Flynn HW: Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol 1996, 114:943-949.
20. Higginbotham EJ, Stevens RK, Musch DC, Karp KO, Lichter PR, Bergstrom TJ, Skuta GL: Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology 1996, 103:650-656.
21. Ayyala RS, Bellows AR, Thomas JV, Hutchinson BT: Bleb infections: clinically different courses of "blebitis" and endophthalmitis. Ophthalmic Surg Lasers 1997, 28:452-460.
22. Greenfield DS, Parrish RK: Bleb rupture following filtering surgery with mitomycin C: clinicopathological correlations. Ophthalmic Surg Lasers 1996, 27:876-877.
23. Richter CU, Shingleton BJ, Bellows AR, Hutchinson BT, O'Connor T, Brill I: The development of encapsulated filtering blebs. Ophthalmology 1988, 95:1163-1168. Retrospective study of 409 filtering operations to identify risk factors for the development of an encapsulated bleb after trabeculectomy. Risk factors were previous therapy with beta-adrenergic antagonists, previous argon laser trabeculoplasty, and age.
24. Feldmann RM, Gross RL, Spaeth GL, Steinmann WC, Varma R, Katz J, Wilson RP, Moster MR, Spiegel D: Risk factors for the development of Tenon's capsule cyst after trabeculectomy. Ophthalmology 1989, 96:336-341.
25. Lavin MJ, Wormald RP, Migdal CS, Hitchings RA: The influence of prior therapy on the success of trabeculectomy. Arch Ophthalmol 1990, 108:1543-1548.
26. Khaw PT, Migdal CS: Current techniques in wound healing modulation in glaucoma surgery. Curr Opin Ophthalmol 1996, 7:24-33.
27. Prata JA, Seah SK, Minckler DS, Baerveldt G, Lee PP, Heuer DK: Postoperative complications and short-term outcome after 5-fluorouracil or mitomycin C trabeculectomy. Journal of Glaucoma 1995, 4:25-31.
28. Azuara-Blanco A, Bond JB, Wilson RP, Moster MR, Schmidt CM: Encapsulated filtering blebs after trabeculectomy with mitomycin-C. Ophthalmic Surg Lasers 1997, 28:805-809.
29. Robin AL, Ramakrishnan P, Krishnadas R, Smith SD, Katz JD, Selvaraj S, Skuta GL, Bhatnagar R: A long-term dose-response study of mitomycin in glaucoma filtration surgery. Arch Ophthalmol 1997, 115:969-974.
30. Costa VP, Comegno PEC, Vasconcelos JPC, Malta RFS, Jose K: Low-dose mitomycin C trabeculectomy in patients with advanced glaucoma. Journal of Glaucoma 1996, 5:193-199.
31. Mora JS, Nguyen N, Iwach AG, Gaffney MM, Hetherington J, Hoskins HD. Wong PC, Tran HT, Dickens CJ: Trabeculectomy with intraoperative sponge of 5-fluorouracil. Ophthalmology 1996, 103:963-970.
32. Chen PP, Yamamoto T, Sawada A, Parrish RK, Kitazawa Y: Use of antifibrosis agents and glaucoma drainage devices in the American and Japanese glaucoma societies. Journal of Glaucoma 1997, 6:192-196.
33. Rabowsky JH, Dukes AJ, Lee DA, Leong KW: The use of bioerodible polymers and daunorubicin in glaucoma filtration surgery. Ophthalmology 1996, 103:800-807.
34. Turacli ME, Güngüz K, Aktan G, Spencer H: Topical cyclosporine as a possible antimetabolite in trabeculectomy. Ophthalmic Surg Lasers 1996, 27:438-444.
35. Costa VP, Spaeth GL, Eiferman RA, Orengo-Nania S: Wound healing modulation in glaucoma filtration surgery. Ophthalmic Surg Lasers 1993, 24:152-170.
36. Skuta GL, Parrish RK: Wound healing in glaucoma filtering surgery. Surv Ophthalmol 1987, 32:149-170. Survey of wound healing processes after glaucoma surgery in correlation to clinical and histopathologic findings. Discussion of factors (clinical factors, physiologic factors such as aqueous humor) and specific methods (corticosteroids, antimetabolites) that may affect or improve surgical success.
37. Powers TP, Stewart WC, Stroman GA: Ultrastructural features of filtration blebs with different clinical appearances. Ophthalmic Surg Lasers 1996, 27:790-794.
38. Addicks EM, Quigley HA, Green R, Robin AL. Histological characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol 1983, 101:795-798. Examination of six functioning and four failed filtering blebs by light and electron microscopy.
39. Hitchings RA, Grierson I: Clinicopathological correlation in eyes with failed fistulizing surgery. Trans Ophthalmol Soc UK 1983, 103:84-88. Comparison of early-failed and late-failed filtering blebs (22 eyes) by light and electron microscopy.
40. Van Buskirk EM: Cysts of Tenon's capsule following filtration surgery. Am J Ophthalmol 1982, 94:522-527.
41. Chen CW: Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of mitomycin C. Trans Asia Pacific Acad Ophthalmol 1983, 91:172-177.
42. Mietz H, Arnold G, Kirchhof B, Diestelhorst M, Krieglstein GK: Histopathology of episcleral fibrosis after trabeculectomy with and without mitomycin C. Graefes Arch Clin Exp Ophthalmol 1996, 234:364-368.
43. Shields MB, Scroggs MW, Sloop CM, Simmons RB: Clinical and histopathological observations concerning hypotony after trabeculectomy with adjunctive mitomycin C. Am J Ophthalmol 1993, 116:673-683.
44. Hutchinson AK, Grossniklaus HE, Brown RH, McManus PE, Bradley CK: Clinicopathologic features of excised mitomycin filtering blebs. Arch Ophthalmol 1994, 112:74-79. Examination of two filtering blebs after trabeculectomy with mitomycin C (MMC) by light and electron microscopy. The inflammatory response seems to be reduced, but not completely suppressed by MMC.
45. Broadway DC, Grierson I, Hitchings RA: Adverse effects of topical antiglaucomatous medications on the conjunctiva. Br J Ophthalmol 1993, 77:790-796.
46. Broadway DC, Grierson I, O'Brien C, Hitchings RA: Adverse effects of topical antiglaucomatous medications, I: the conjunctival cell profile. Arch Ophthalmol 1994, 112:1437-1445.
47. Sherwood MB, Grierson I, Millar L, Hitchings RA: Long-term morphological effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous eyes. Ophthalmology 1989, 96:327-335. Comparison of conjunctival and Tenon's capsule biopsies from patients with and without treatment increases the number of tissue inflammatory cells.
48. Broadway DC, Grierson I, Stürmer J, Hitchings RA: Reversal of topical antiglaucoma medication effects on the conjunctiva. Arch Ophthalmol 1996, 114:252-267. Conjunctival changes induced by topical combination therapy can be reversed by stopping therapy with sympatomimetics and beginning treatment with topical fluorometholone for 1 month.